Svb Wealth LLC Bristol Myers Squibb CO Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $292,698 - $385,343	-7,272 Reduced 7.74%	86,707 $3.6 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $25,717 - $29,158	536 Added 0.57%	93,979 $5.1 Million
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $17,792 - $21,230	367 Added 0.39%	93,443 $4.79 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $679,107 - $759,347	-11,731 Reduced 11.19%	93,076 $5.4 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $626,078 - $695,161	-9,827 Reduced 8.57%	104,807 $6.7 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $576,473 - $653,851	-8,773 Reduced 7.11%	114,634 $7.95 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $986,796 - $1.17 Million	-14,410 Reduced 10.46%	123,407 $8.88 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $1,658 - $980,478	12,760 Added 10.2%	137,817 $9.8 Million
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $86,490 - $95,256	1,191 Added 0.96%	125,057 $9.63 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $66,828 - $80,133	-1,087 Reduced 0.87%	123,866 $9.05 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $145,819 - $169,991	-2,719 Reduced 2.13%	124,953 $7.79 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $174,610 - $204,533	-2,951 Reduced 2.26%	127,672 $7.56 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $138,987 - $151,357	-2,245 Reduced 1.69%	130,623 $8.73 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $88,475 - $99,509	1,491 Added 1.13%	132,868 $8.39 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $501,009 - $567,736	-8,677 Reduced 6.2%	131,377 $8.15 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $85,685 - $94,950	-1,492 Reduced 1.05%	140,054 $8.44 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $137,324 - $160,545	-2,505 Reduced 1.74%	141,546 $8.32 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $403,912 - $586,978	-8,705 Reduced 5.7%	144,051 $8.03 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $2.57 Million - $3.35 Million	52,233 Added 51.96%	152,756 $9.81 Million
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $207,776 - $246,349	-4,858 Reduced 4.61%	100,523 $5.1 Million
Q2 2019 Jul 10, 2019	SELL	$44.62 - $49.34 $41,764 - $46,182	-936 Reduced 0.88%	105,381 $4.78 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $1.67 Million - $1.99 Million	-37,065 Reduced 25.85%	106,317 $5.07 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $114,683 - $148,716	-2,352 Reduced 1.61%	143,382 $7.45 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $271,645 - $306,394	-4,922 Reduced 3.27%	145,734 $9.05 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $155,632 - $193,978	-3,080 Reduced 2.0%	150,656 $8.34 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $590,691 - $680,004	-9,858 Reduced 6.03%	153,736 $9.72 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $249,590 - $272,117	-4,164 Reduced 2.48%	163,594 $10 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $9.27 Million - $10.7 Million	167,758	167,758 $10.7 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account